cs-7017
Showing 1 - 7 of 7
NSCLC Trial in Seoul (CS-7017, Erlotinib)
Completed
- Carcinoma, Non-Small-Cell Lung
- CS-7017
- Erlotinib
-
Seoul, Songpa-Gu, Korea, Republic ofAsan Medical Center
Apr 16, 2021
Advanced Cancer Trial in Washington (CS-7017)
Completed
- Advanced Cancer
- CS-7017
-
Washington, District of Columbia(unnamed)
Sep 2, 2020
NSCLC Trial in Seoul (CS-7017, Carboplatin, Paclitaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- CS-7017
- +2 more
-
Seoul, Gangnam-gu, Korea, Republic ofSamsung Medical Center
Jun 23, 2020
Anaplastic Thyroid Cancer Trial in United States (CS-7017, Paclitaxel)
Advanced NSCLC (NSCLC) Trial in Worldwide (CS-7017, erlotinib)
Completed
- Advanced Non-small Cell Lung Cancer (NSCLC)
- CS-7017
- erlotinib
-
Denver, Colorado
- +16 more
Jun 12, 2020